Monteiro Vasconcelos Felipe, Cabral Pereira da Costa Carolina, Peres Ellen M, Souza Leão Robson, Ferraz Gomes Helena, Silva Thiengo Andrade Priscila C, Silva Pires Ariane, Faria Cristiene, Oliveira Motta Ana Paula, Barreto Pires Bruna Maiara Ferreira
Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil.
Wounds. 2022 Feb;33(2):51-56. doi: 10.25270/wnds/2022.5156.
Colonization of a pressure injury with microorganisms can negatively affect wound healing. Thus, it is necessary to evaluate which products best facilitate wound healing.
This case series evaluated the effectiveness of the antimicrobial polyhexamethylene biguanide (PHMB) on microorganisms in pressure injuries.
Fourteen patients (14 wounds) were treated with PHMB in the hospital setting after collection of a wound swab sample for microbiological analysis and determination of the risk profile using the disk diffusion method.
Thirteen lesions (92.9%) were positive for 1 or more bacterial strains, the most prevalent of which were Staphylococcus aureus and Pseudomonas aeruginosa. Two strains of methicillin-resistant S aureus (MRSA) were also identified. Klebsiella pneumoniae demonstrated 100% resistance to the tested antibiotics, with Acinetobacter demonstrating 90% resistance, P aeruginosa 88.9%, Citrobacter freundii 87.5%, S aureus 66.7%, and MRSA 57.1%. Only Serratia marcescens demonstrated no resistance to any antibiotic tested. Polyhexamethylene biguanide was effective only against strains of S marcescens, which were not present in the second wound swab sample collected (after the application of PHMB); other microorganisms were present in the second wound swab sample collected.
Polyhexamethylene biguanide has an immediate antimicrobial effect on S marcescens. However, it had no qualitative effect on the other microorganisms. Studies with larger populations and randomized clinical trial methodologies are necessary to elucidate additional findings concerning the effectiveness of PHMB in managing microorganisms in pressure injuries.
压力性损伤被微生物定植会对伤口愈合产生负面影响。因此,有必要评估哪些产品最有助于伤口愈合。
本病例系列评估了抗菌剂聚六亚甲基双胍(PHMB)对压力性损伤中微生物的有效性。
14例患者(14处伤口)在医院接受PHMB治疗,此前采集伤口拭子样本进行微生物分析,并使用纸片扩散法确定风险特征。
13处损伤(92.9%)检测出1种或更多菌株呈阳性,其中最常见的是金黄色葡萄球菌和铜绿假单胞菌。还鉴定出2株耐甲氧西林金黄色葡萄球菌(MRSA)。肺炎克雷伯菌对所测试的抗生素表现出100%耐药,不动杆菌耐药率为90%,铜绿假单胞菌为88.9%,弗氏柠檬酸杆菌为87.5%,金黄色葡萄球菌为66.7%,MRSA为57.1%。只有黏质沙雷菌对所测试的任何抗生素均无耐药性。聚六亚甲基双胍仅对黏质沙雷菌菌株有效,在采集的第二次伤口拭子样本(应用PHMB后)中未发现该菌株;在采集的第二次伤口拭子样本中存在其他微生物。
聚六亚甲基双胍对黏质沙雷菌有即时抗菌作用。然而,它对其他微生物没有定性影响。需要进行更大规模人群的研究和随机临床试验方法,以阐明关于PHMB在处理压力性损伤中微生物有效性的更多发现。